Clinical trial

BIO|CONCEPT.Amvia Study

NCT05610176

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-11-23

PhaseNA

Study timeline

Study start (actual)2022-11-23Date precision: day

Registry last updated2025-07-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Bradycardiaunresolved

Heart Failureunresolved

Interventions

Amvia Sky pacemaker or CRT-P deviceDEVICE

Sponsors & collaborators

Biotronik Australia Pty Ltd.lead sponsor

Biotronik SE & Co. KGcollaborator

Mapped research locations

MelbourneVictoria, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05610176 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.